BridgeMD
Tests treatment safety and results for Chronic Idiopathic Anopérineal Pain
Official title EFFICACY of USUAL MANAGEMENT of CHRONIC IDIOPATHIC ANO-PERINEAL PAIN by USING LOCAL ANESTHETIC INFILTRATION
ClinicalTrials.gov ID: NCT06602349
What this study is testing
What is Lidocaine 10 MG/ML?
Lidocaine 10 MG/ML is an investigational medicine, given as an injectable medicine, being studied as a potential treatment for chronic idiopathic anopérineal pain.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this clinical trial is to evaluate the efficacy of a posterior perineal block performed under neurostimulation at 1 month after local anesthetic infiltration in the treatment of chronic idiopathic ano-perineal pain. The main questions aims to answer are : 1.
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patient 18 years of age or older,
- Express consent to participate in the study
- Affiliated or beneficiary of a social security plan
- Presenting chronic idiopathic ano-perineal pain
- MRI normal or without pathology explaining pain (Multidisciplinary consultation meeting reread if in doubt)
You likely can't join if
- Patient benefiting from a legal protection measure
- Pregnant or breast-feeding woman
- General and/or local infection (fistulous or cutaneous suppuration of anal margin) in progress
- Known neurological pathology that may explain pain
- Psychiatric pathology requiring medication
- Anticoagulants or haemostasis disorders
See the full eligibility criteria
- Patient 18 years of age or older,
- Express consent to participate in the study
- Affiliated or beneficiary of a social security plan
- Presenting chronic idiopathic ano-perineal pain
- MRI normal or without pathology explaining pain (Multidisciplinary consultation meeting reread if in doubt)
- Resistance to \"standard\" 1st-line medical treatment (level 1 or 2 analgesics and/or non-steroidal anti-inflammatory and/or local topicals)
- Patient benefiting from a legal protection measure
- Pregnant or breast-feeding woman
- General and/or local infection (fistulous or cutaneous suppuration of anal margin) in progress
- Known neurological pathology that may explain pain
- Psychiatric pathology requiring medication
- Anticoagulants or haemostasis disorders
- Hypersensitivity to lidocaine hydrochloride or local anesthetics
- Recurrent porphyrias
The study team makes the final eligibility decision.
Where it's taking place
- Paris, Île-de-France Region, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Paris, Île-de-France Region, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.